Mathilde Lemitre
Impact in
-
- Cardiac Fibrosis and Remodeling
-
- Atherosclerosis and Cardiovascular Diseases
Papers in
-
- MicroRNA in disease regulation 2
- Co-authors
- Antoine LafontGiuseppina CaligiuriAyman Al Haj ZenJulie SainzCorinne DemerensJean‐Sébastien SilvestreDominique UrbainJosé Vilar
- Journals
- Arteriosclerosis Thrombosis and Vascular Biology (3 papers)Circulation (2 papers)Journal of Vascular Research (1 paper)European Heart Journal (1 paper)Atherosclerosis (1 paper)
- Partner nations
- FranceUnited KingdomCanada
In The Last Decade
Mathilde Lemitre
15 papers receiving 675 citations
Peers
Comparison fields: 5 of 69
- Cardiology and Cardiovascular Medicine 171
- Immunology 156
- Genetics 78
- Cancer Research 108
- Immunology and Allergy 33
Countries citing papers authored by Mathilde Lemitre
This map shows the geographic impact of Mathilde Lemitre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathilde Lemitre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathilde Lemitre more than expected).
Fields of papers citing papers by Mathilde Lemitre
This network shows the impact of papers produced by Mathilde Lemitre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathilde Lemitre. The network helps show where Mathilde Lemitre may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mathilde Lemitre, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 39 | |
| 2 | 2022 | 1 | |
| 3 | 2022 | 3 | |
| 4 | 2020 | 10 | |
| 5 | 2019 | 64 | |
| 6 | 2016 | 144 | |
| 7 | 2016 | 127 | |
| 8 | 2013 | 20 | |
| 9 | 2012 | 12 | |
| 10 | 2012 | 14 | |
| 11 | 2009 | 8 | |
| 12 | 2008 | 37 | |
| 13 | 2005 | 128 | |
| 14 | 2005 | 42 | |
| 15 | 2005 | 36 |
About Mathilde Lemitre
Mathilde Lemitre is a scholar working on Immunology and Allergy, Cancer Research, Sensory Systems, Immunology and Neurology, having authored 15 papers that have together received 685 indexed citations. Recurring topics across this work include Aortic aneurysm repair treatments (3 papers), Cardiac Fibrosis and Remodeling (3 papers), Extracellular vesicles in disease (2 papers), Tissue Engineering and Regenerative Medicine (2 papers), MicroRNA in disease regulation (2 papers), Intracranial Aneurysms: Treatment and Complications (2 papers), Adipokines, Inflammation, and Metabolic Diseases (2 papers) and Coronary Interventions and Diagnostics (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (171 citations), Immunology (156 citations), Genetics (78 citations), Cancer Research (108 citations) and Immunology and Allergy (33 citations). Mathilde Lemitre has collaborated with scholars based in France, United Kingdom and Canada. Frequent co-authors include Antoine Lafont, Giuseppina Caligiuri, Ayman Al Haj Zen, Julie Sainz, Corinne Demerens, Jean‐Sébastien Silvestre, Dominique Urbain, José Vilar, Ivana Zlatanova and Ziad Mallat. Their work appears in journals such as Arteriosclerosis Thrombosis and Vascular Biology, Circulation, Journal of Vascular Research, European Heart Journal and Atherosclerosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.